Neuroimaging Is Estimated To Witness High Growth Owing To Rise In Prevalence Of Neurological Disorders
Neuroimaging market |
The Neuroimaging market is estimated to be valued at US$ 37.63 Bn in 2023 and is expected to exhibit a CAGR of 6.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Neuroimaging encompasses various medical imaging techniques used to
visualize the structure and function of the brain and spinal cord. It is
conducted using imaging modalities such as computerized tomography (CT),
magnetic resonance imaging (MRI), positron emission tomography (PET), and
ultrasound. These imaging techniques provide valuable insights into the brain
anatomy and physiology, and aid in the diagnosis and treatment of various
neurological disorders such as Alzheimer's disease, dementia, epilepsy, and
stroke. Growth in geriatric population and rising prevalence of neurological
disorders globally are key factors driving the demand for neuroimaging
procedures.
Market Dynamics:
One of the major drivers propelling the neuroimaging market growth is the
rising prevalence of neurological disorders. According to the World Health
Organization (WHO), neurological disorders account for approximately 6.8% of
the global disease burden, with an estimated 1 billion people affected
worldwide each year. Conditions such as Alzheimer's disease, dementia, stroke,
epilepsy, multiple sclerosis, headache disorders, and others are on the rise
globally. This has increased the uptake of neuroimaging procedures for
diagnosis and monitoring of treatment efficacy. Furthermore, advancements in
neuroimaging technologies such as high-field MRI systems, micro-MRI scanners,
and hybrid imaging modalities like PET/MRI and PET/CT are enabling superior
visualization of brain structures and functions. This is supporting early and
accurate diagnosis of neurological conditions. Growing applications of
neuroimaging in neuroscience research and developmental studies is another
factor fueling the market growth.
SWOT Analysis
Strength: Neuroimaging market has
high growth potential as neurological disorders are on the rise. Advancements
in scanning technologies provide more accurate diagnostics. Growing awareness
has increased demand for neuroimaging tests.
Weakness: High costs associated with
neuroimaging equipment limits access in developing nations. Stringent
regulations delay product approval and market entry. Lack of skilled
professionals impedes effective diagnostics.
Opportunity: Untapped markets in
Asia Pacific and Latin America offer scope for market expansion. Personalized
neuroimaging based on AI and machine learning can improve outcomes. Combining
neuroimaging data with other modalities creates new application areas.
Threats: Strict privacy and data protection laws increase compliance costs.
Reimbursement issues pose challenges. Low diagnosis rates in developing
countries constrain revenue growth. Intense competition threatens market share
of existing players.
Key Takeaways
The Global Neuroimaging
Market Trend is expected to witness high growth, exhibiting CAGR of
6.0% over the forecast period, due to increasing incidence of neurological
disorders. Rise in trauma and accident cases boosts demand for neuroimaging
procedures.
North America dominates the global neuroimaging market currently. Higher
adoption of advanced technologies and rising healthcare spending drive the
North America market. Asia Pacific is projected to grow at the fastest pace
during the forecast period, led by economic development, growing medical
tourism, and increasing healthcare investments in India and China.
Key players operating in the neuroimaging market are GE Healthcare, Siemens
Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation, Hitachi
Healthcare, Canon Medical Systems Corporation, Mindray Medical International
Limited, Esaote SpA, NeuroLogica Corporation, NeuroVive Pharmaceutical AG,
Brainlab AG, Akili Interactive Labs Inc., Brainomix Ltd., Imaging Science
International, Mevis Medical Solutions, NeuroVista, Neusoft Medical Systems,
Positron Corporation, Shimadzu Corporation, Trifoil Imaging. These players are
focusing on new product launches and partnerships to strengthen their market
position.
Comments
Post a Comment